Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Liabilities: 2013-2019

Historic Total Liabilities for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $13.8 million.

  • Soleno Therapeutics' Total Liabilities fell 16.78% to $13.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $13.8 million, marking a year-over-year decrease of 16.78%. This contributed to the annual value of $12.7 million for FY2018, which is 4.37% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Total Liabilities of $13.8 million as of Q3 2019, which was down 31.79% from $20.3 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Total Liabilities ranged from a high of $21.4 million in Q1 2015 and a low of $2.1 million during Q4 2016.
  • Its 3-year average for Total Liabilities is $11.9 million, with a median of $13.1 million in 2018.
  • In the last 5 years, Soleno Therapeutics' Total Liabilities tumbled by 83.36% in 2016 and then soared by 473.10% in 2017.
  • Over the past 5 years, Soleno Therapeutics' Total Liabilities (Quarterly) stood at $5.0 million in 2015, then tumbled by 57.21% to $2.1 million in 2016, then spiked by 473.10% to $12.2 million in 2017, then climbed by 4.37% to $12.7 million in 2018, then fell by 16.78% to $13.8 million in 2019.
  • Its last three reported values are $13.8 million in Q3 2019, $20.3 million for Q2 2019, and $15.2 million during Q1 2019.